ARIAD to Present at the Jefferies 2016 London Healthcare Conference
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2016 London
Healthcare Conference. Company management will provide an overview of the Company’s business on Wednesday, November 16, 2016 at
4:40 p.m. (GMT).
The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's
website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for
three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing
precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of
chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.
For Investors
Jennifer Robinson, 617-503-7298
Jennifer.robinson@ariad.com
or
For Media
Liza Heapes, 617-621-2315
Liza.heapes@ariad.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102005764/en/